Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Arth-by-Emcure"

2 News Found

Dhoni joins Arth by Emcure to tackle iron deficiency on World Iron Deficiency Day
Healthcare | November 27, 2025

Dhoni joins Arth by Emcure to tackle iron deficiency on World Iron Deficiency Day

M. S. Dhoni and Emcure's Namita Thapar unite to champion women's health awareness
News | February 02, 2025

M. S. Dhoni and Emcure's Namita Thapar unite to champion women's health awareness

Arth by Emcure is a specialized range of supplements designed to address the unique health and wellness needs of women, enabling them to lead healthier and happier lives across all stages

Latest Stories

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

Alphatec and Theradaptive forge landmark spine partnership as Series B round launches

Redesigned brain receptor drugs show promise for depression

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories
Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging